Article type
Year
Abstract
Objectives:
(i) Enable participants to identify the pitfalls/ difficulties/problems in reporting adverse events. (ii) Provide guidance on how to report adverse effects in reviews (PRISMA Harms Extension). (iii) Allow participants to practice methods of clear reporting of adverse events in reviews.
Description:
Present the quality issues in reporting adverse effects using ‘Quality in reporting in systematic reviews of adverse events. A systematic review.’ (15 minutes) Present a tool to assess the quality of reporting in reviews: The PRISMA Harms Extension + final checklist items. (15 minutes) The participants will break into small groups to apply the PRISMA Harms Extension checklist in systematic reviews of adverse events. They will assess 2–4 published reviews. The example reviews will include reviews with good reporting quality and reviews with fair (not good) reporting of adverse events (60 minutes). After each assessment the participants will discuss the application of the guidance and issues raised in assessing the reporting of adverse effects in reviews. This section will be an open for questions/discussion among participants.
(i) Enable participants to identify the pitfalls/ difficulties/problems in reporting adverse events. (ii) Provide guidance on how to report adverse effects in reviews (PRISMA Harms Extension). (iii) Allow participants to practice methods of clear reporting of adverse events in reviews.
Description:
Present the quality issues in reporting adverse effects using ‘Quality in reporting in systematic reviews of adverse events. A systematic review.’ (15 minutes) Present a tool to assess the quality of reporting in reviews: The PRISMA Harms Extension + final checklist items. (15 minutes) The participants will break into small groups to apply the PRISMA Harms Extension checklist in systematic reviews of adverse events. They will assess 2–4 published reviews. The example reviews will include reviews with good reporting quality and reviews with fair (not good) reporting of adverse events (60 minutes). After each assessment the participants will discuss the application of the guidance and issues raised in assessing the reporting of adverse effects in reviews. This section will be an open for questions/discussion among participants.